Federal spending under NAICS 325413 is concentrated in health and defense buying activity, led by the Department of the Army, the Defense Logistics Agency, and the Office of Assistant Secretary for Preparedness and Response. On the vendor side, Abbott Rapid Dx North America, iHealth Labs, Roche Diagnostics, Siemens Healthcare Diagnostics, and Cepheid account for the largest obligations in the period.
NAICS Industry
NAICS 325413 Federal Contract Obligations (Last 10 Years)
NAICS 325413 covers federal contract activity for in-vitro diagnostic substance manufacturing, with $11.14 billion obligated across 40,162 actions in the last 10 years.
Annual obligations peaked in 2022 at $6.01 billion, while 2024 and 2025 show lower totals; counts remain steady at roughly 3,400 to 4,100 actions per year in the most recent five years shown.
NAICS Code
325413
Industry
IN-VITRO DIAGNOSTIC SUBSTANCE MANUFACTURING
Total Obligated
11.14 billion
11,137,011,337.40
Award Actions
40,162
Average Action Value
277,302.20
About NAICS 325413 federal contract activity
NAICS 325413 covers in-vitro diagnostic substance manufacturing and shows 11.14 billion in obligated federal spending across 40,162 awards over the last 10 years, with an average award value of 277,302.2. Procurement activity is concentrated in health, defense, and preparedness-related missions, indicating sustained demand for diagnostic reagents, test materials, and related supplies.
Agency demand and leading federal buyers
The Department of the Army leads all agencies with 4.88 billion across 5,954 awards, followed by the Defense Logistics Agency at 2.18 billion across 2,834 awards. The Office of Assistant Secretary for Preparedness and Response, Veterans Affairs, and the Health Resources and Services Administration also account for significant spend, reflecting the role of diagnostic substances in force health protection, emergency readiness, patient care, and public health operations.
Vendor concentration and leading contractors
ABBOTT RAPID DX NORTH AMERICA, LLC is the largest vendor by obligations at 3.38 billion across 671 awards, followed by IHEALTH LABS INC. at 2.13 billion across 12 awards. ROCHE DIAGNOSTICS CORPORATION, SIEMENS HEALTHCARE DIAGNOSTICS INC., and CEPHEID also appear among the top vendors, with award volumes suggesting a mix of recurring supply arrangements and high-dollar procurement actions.
Annual contract trend over the analysis window
Annual obligations show a pronounced spike in 2022 at 6.01 billion, far above the other years in the displayed period. Spending then fell to 894.42 million in 2023 and declined further in 2024 and 2025 to 144.95 million and 166.19 million, while award counts remained relatively high, indicating continued procurement activity at lower dollar levels.
How to interpret this page
Figures are based on FPDS awards matched to NAICS 325413 for the last 10 years. Obligations, award counts, and averages reflect the data available in the query results and should be interpreted as procurement activity reported under this NAICS code, not as a complete measure of industry output.
Top Agencies
SELECT
agency_id,
agency_name,
total_obligated,
award_count,
formatReadableQuantity(total_obligated) AS total_obligated_readable
FROM
(
SELECT
content__award__purchaserInformation__contractingOfficeAgencyID AS agency_id,
anyHeavy(content__award__purchaserInformation__contractingOfficeAgencyID__name) AS agency_name,
sum(content__award__dollarValues__obligatedAmount) AS total_obligated,
count() AS award_count
FROM fpds.data
WHERE
contract_type = 1
AND content__award__productOrServiceInformation__principalNAICSCode = '325413'
AND content__award__purchaserInformation__contractingOfficeAgencyID IS NOT NULL
AND content__award__purchaserInformation__contractingOfficeAgencyID != ''
AND parseDateTimeBestEffortOrNull(content__award__relevantContractDates__signedDate) >= toStartOfYear(now()) - INTERVAL 10 YEAR
AND parseDateTimeBestEffortOrNull(content__award__relevantContractDates__signedDate) < toStartOfYear(now())
GROUP BY agency_id
)
ORDER BY total_obligated DESC
LIMIT 10| Agency ID | Agency Name | Total Obligated | Readable | Award Actions |
|---|---|---|---|---|
| 2100 | DEPT OF THE ARMY | 4,876,879,892.94 | 4.88 billion | 5,954 |
| 97AS | DEFENSE LOGISTICS AGENCY | 2,184,586,635.12 | 2.18 billion | 2,834 |
| 7505 | OFFICE OF ASSISTANT SECRETARY FOR PREPAREDNESS AND RESPONSE | 1,469,003,215.27 | 1.47 billion | 201 |
| 3600 | VETERANS AFFAIRS, DEPARTMENT OF | 1,411,400,535.06 | 1.41 billion | 17,188 |
| 7526 | HEALTH RESOURCES AND SERVICES ADMINISTRATION | 447,436,113.48 | 447.44 million | 17 |
| 5700 | DEPT OF THE AIR FORCE | 176,034,320.23 | 176.03 million | 998 |
| 7527 | INDIAN HEALTH SERVICE | 134,985,311.59 | 134.99 million | 3,173 |
| 1700 | DEPT OF THE NAVY | 111,042,900.91 | 111.04 million | 3,206 |
| 97DH | DEFENSE HEALTH AGENCY (DHA) | 94,045,804.55 | 94.05 million | 1,091 |
| 7529 | NATIONAL INSTITUTES OF HEALTH | 81,564,398.87 | 81.56 million | 2,617 |
Insight
Over the last 10 years, NAICS 325413 has obligated $11.14 billion across 40,162 awards, with spending concentrated in a small set of agencies. The Department of the Army leads with $4.88 billion, followed by the Defense Logistics Agency at $2.18 billion and the Office of Assistant Secretary for Preparedness and Response at $1.47 billion; these three agencies account for the majority of reported obligations. Veterans Affairs also represents a major buyer at $1.41 billion and 17,188 awards, indicating broad, recurring procurement activity, while the remaining agencies each contribute materially smaller shares of total spend.
Top Vendors
SELECT
vendor_name,
cage_code,
total_obligated,
award_count,
formatReadableQuantity(total_obligated) AS total_obligated_readable
FROM
(
SELECT
content__award__vendor__vendorHeader__vendorName AS vendor_name,
anyHeavy(content__award__vendor__vendorSiteDetails__entityIdentifiers__cageCode) AS cage_code,
sum(content__award__dollarValues__obligatedAmount) AS total_obligated,
count() AS award_count
FROM fpds.data
WHERE
contract_type = 1
AND content__award__productOrServiceInformation__principalNAICSCode = '325413'
AND content__award__vendor__vendorHeader__vendorName IS NOT NULL
AND content__award__vendor__vendorHeader__vendorName != ''
AND parseDateTimeBestEffortOrNull(content__award__relevantContractDates__signedDate) >= toStartOfYear(now()) - INTERVAL 10 YEAR
AND parseDateTimeBestEffortOrNull(content__award__relevantContractDates__signedDate) < toStartOfYear(now())
GROUP BY vendor_name
)
ORDER BY total_obligated DESC
LIMIT 10| Vendor | CAGE Code | Total Obligated | Readable | Award Actions |
|---|---|---|---|---|
| ABBOTT RAPID DX NORTH AMERICA, LLC | 5C4F2 | 3,375,962,582.27 | 3.38 billion | 671 |
| IHEALTH LABS INC. | 75EV5 | 2,132,749,987.20 | 2.13 billion | 12 |
| ROCHE DIAGNOSTICS CORPORATION | 51169 | 835,500,364.91 | 835.50 million | 2,891 |
| SIEMENS HEALTHCARE DIAGNOSTICS INC. | 1K2V6 | 634,216,196.26 | 634.22 million | 1,050 |
| CEPHEID | 07YE7 | 464,881,456.34 | 464.88 million | 2,196 |
| REMEL INC. | 7V410 | 453,593,698.60 | 453.59 million | 193 |
| ACCESS BIO, INC. | 3CNE1 | 340,654,000.00 | 340.65 million | 9 |
| QUIDEL CORPORATION | 0TH42 | 194,253,073.18 | 194.25 million | 143 |
| LIFE TECHNOLOGIES CORPORATION | 1F3R7 | 152,227,724.42 | 152.23 million | 344 |
| BECTON, DICKINSON AND COMPANY | 22790 | 116,509,965.81 | 116.51 million | 667 |
Insight
Obligations in NAICS 325413 are highly concentrated among a small number of vendors over the last 10 years. ABBOTT RAPID DX NORTH AMERICA, LLC leads with $3.38 billion across 671 awards, followed by IHEALTH LABS INC. with $2.13 billion across only 12 awards, indicating a very large-dollar, low-frequency award pattern for that vendor. The next tier—ROCHE DIAGNOSTICS CORPORATION, SIEMENS HEALTHCARE DIAGNOSTICS INC., and CEPHEID—shows materially lower but still significant obligated amounts, with award activity more dispersed. Overall, the top 10 vendors account for a substantial share of the $11.14 billion obligated in this NAICS.
Annual Trend
SELECT
year,
total_obligated,
award_count,
formatReadableQuantity(total_obligated) AS total_obligated_readable
FROM
(
SELECT
toYear(parseDateTimeBestEffortOrNull(content__award__relevantContractDates__signedDate)) AS year,
sum(content__award__dollarValues__obligatedAmount) AS total_obligated,
count() AS award_count
FROM fpds.data
WHERE
contract_type = 1
AND content__award__productOrServiceInformation__principalNAICSCode = '325413'
AND parseDateTimeBestEffortOrNull(content__award__relevantContractDates__signedDate) >= toStartOfYear(now()) - INTERVAL 10 YEAR
AND parseDateTimeBestEffortOrNull(content__award__relevantContractDates__signedDate) < toStartOfYear(now())
GROUP BY year
)
ORDER BY year DESC| Year | Total Obligated | Readable | Award Actions |
|---|---|---|---|
| 2025 | 166,185,427.47 | 166.19 million | 3,442 |
| 2024 | 144,947,473.82 | 144.95 million | 3,851 |
| 2023 | 894,419,644.93 | 894.42 million | 3,812 |
| 2022 | 6,010,227,073.85 | 6.01 billion | 4,144 |
| 2021 | 1,254,696,843.18 | 1.25 billion | 4,533 |
| 2020 | 1,908,448,839.75 | 1.91 billion | 4,557 |
| 2019 | 196,951,844.38 | 196.95 million | 3,672 |
| 2018 | 171,488,227.44 | 171.49 million | 3,818 |
| 2017 | 222,445,152.44 | 222.45 million | 4,266 |
| 2016 | 167,200,810.14 | 167.20 million | 4,067 |
Insight
Obligations in NAICS 325413 are highly concentrated in 2020-2023, which account for the bulk of the 10-year total of $11.14 billion. FY2022 is the clear outlier at $6.01 billion, far exceeding every other year, while FY2020 ($1.91 billion) and FY2021 ($1.25 billion) also represent elevated spending relative to the pre-2020 period. Award counts are comparatively stable across the period, ranging from 3,442 to 4,557, indicating that the volatility is driven primarily by obligation value rather than transaction volume.
Use FPDS Query for deeper industry analysis
Explore federal procurement data with custom SQL, fast filtering, and deeper industry analysis across agencies, vendors, and annual trends.
Continue from this last 10 years view into full FPDS Query workflows with deeper filtering, custom SQL, saved queries, and broader market comparison.